Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2000 Jun;2(3):238-45.
doi: 10.1007/s11926-000-0085-8.

Antiphospholipid antibodies and platelets

A De Jong  1 , V Ziboh, D Robbins
Affiliations
Review

Antiphospholipid antibodies and platelets

A De Jong et al. Curr Rheumatol Rep. 2000 Jun.

Abstract

The most distinguishing serologic feature of antiphospholipid syndrome (APS) is the moderate to high blood titers of antiphospholipid-binding antibodies (aPL). The pathogenic mechanisms of APS are poorly understood, but may occur as a result of the interaction between anticardiolipin antibodies (aCL), beta-2 glycoprotein-I (beta(2)GP-I) (the aCL cofactor) and blood platelets. However, the relationship between aCL/beta(2)GP-I complexes and platelet aggregation has yet to be clearly elucidated. This article will briefly review aPL, beta(2)GP-I and platelet physiology with respect to recent hypotheses relating aCL/beta(2)GP-I complexes and platelets.

PubMed Disclaimer

References

    1. Hum Genet. 1997 Jul;100(1):57-62 - PubMed
    1. Lupus. 1995 Aug;4(4):263-71 - PubMed
    1. Br J Haematol. 1985 Feb;59(2):227-30 - PubMed
    1. J Immunol. 1992 Jun 15;148(12):3885-91 - PubMed
    1. Haemostasis. 1996 Oct;26 Suppl 4:340-57 - PubMed

MeSH terms

LinkOut - more resources